Search results
Results from the WOW.Com Content Network
Transient myeloproliferative disease develops and may be of concern in fetuses. Features in a review of 39 reported fetal cases include: reduced platelet production often accompanied by significantly reduced levels of circulating platelets; reduced red blood cell production sometimes accompanied by mild anemia; increased levels of circulating megakaryoblasts and white blood cells; grossly ...
Vesiculopustular eruption and leukemoid reaction in Down syndrome is a cutaneous condition, an extensive neonatal vesiculopustular eruption seen in people with Down syndrome. [ 1 ] See also
The disease is restricted to individuals with Down syndrome or genetic changes similar to those in Down syndrome, develops during pregnancy or shortly after birth, and resolves within 3 months, or in about 10% of cases, progresses to acute megakaryoblastic leukemia. [33] [30] [34]
Mosaic Down syndrome: Only some cells in the person have an extra copy of chromosome 21. This genetic cause is considered rare. This genetic cause is considered rare.
Acute lymphoblastic leukemia in Down syndrome accounts for 1–3% of all childhood cases of ALL. It occurs most often in those older than nine years or having a white blood cell count greater than 50,000 per microliter and is rare in those younger than one year old. ALL in Down syndrome tends to have poorer outcomes than other cases of ALL in ...
The disease is restricted to individuals with Down syndrome or genetic changes similar to those in Down syndrome, develops in a baby during pregnancy or shortly after birth, and resolves within 3 months or, in ~10% of cases, progresses to acute megakaryoblastic leukemia. Transient myeloid leukemia is a pre-leukemic condition. [30] [31] [32]
Genetic disorders that have been linked with an increased chance of developing subleukemic leukemia include ataxia telangiectasia, Bloom syndrome, Down syndrome, Fanconi anemia, and Li–Fraumeni syndrome. [citation needed] Some genes have been inferred to be connected to the disease, but this research is not widespread, accepted knowledge. [2]
The recognition of Hepatitis B antigen occurred in patients with Down’s Syndrome, so they became a related subject of investigation, particularly as a model for leukemia susceptibility. [19] Sutnick was the first to recognize the relationship of iron stores to cancer susceptibility, and reduced life expectancy. [20]